Evidence map›Paper›PMID 30376201›Full record

ArticleNMR in biomedicine2019

Proton MRS of cervical cancer at 7 T.

C S Arteaga de Castro, J P Hoogendam, I M L van Kalleveen, A J E Raaijmakers, R P Zweemer, R H M Verheijen, P R Luijten, W B Veldhuis, D W J Klomp

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NMR in biomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. The contribution of theEuropean radiology experimental · 2022
    Article
  4. Review
  5. Review
  6. Proton MRS of cervical cancer at 7 T.NMR in biomedicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C S Arteaga de CastroDepartment of Radiology, UMC Utrecht, The Netherlands.ORCID 0000-0002-1055-2672
J P HoogendamDepartment of Gynecological Oncology, UMC Utrecht Cancer Center, The Netherlands.
I M L van KalleveenDepartment of Radiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID 0000-0001-8916-4279
A J E RaaijmakersDepartment of Radiology, UMC Utrecht, The Netherlands.
R P ZweemerDepartment of Gynecological Oncology, UMC Utrecht Cancer Center, The Netherlands.
R H M VerheijenDepartment of Gynecological Oncology, UMC Utrecht Cancer Center, The Netherlands.
P R LuijtenDepartment of Radiology, UMC Utrecht, The Netherlands.
W B VeldhuisDepartment of Radiology, UMC Utrecht, The Netherlands.
D W J KlompDepartment of Radiology, UMC Utrecht, The Netherlands.

Funding

STW Technology Foundation 10822
6 · The paper itself

Abstract

The differentiation grade of cervical cancer is histologically assessed by examining biopsies or surgical specimens. MRS is a highly sensitive technique that images tissue metabolism and can be used to increase the specificity of tissue characterization in a non-invasive manner. We aim to explore the feasibility of using in vivo

Indexed as

Proton Magnetic Resonance SpectroscopyAdultAgedFatty AcidsFemaleHumansMiddle AgedNeoplasm GradingUterine Cervical NeoplasmsFatty Acids7 Tcervical cancerfatty acidsFIGO stageMRStumor grade

Identifiers

PMID30376201
PMCPMC6588007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.